These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2548774)

  • 1. Caffeine as indicator of metabolic functions of microsomal liver enzymes.
    Varagnolo M; Plebani M; Mussap M; Nemetz L; Paleari CD; Burlina A
    Clin Chim Acta; 1989 Jul; 183(1):91-4. PubMed ID: 2548774
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma.
    Hobara N; Watanabe A
    Acta Med Okayama; 1979 Oct; 33(5):389-93. PubMed ID: 229696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of caffeine elimination and Child's classification in liver cirrhosis.
    Holstege A; Staiger M; Haag K; Gerok W
    Klin Wochenschr; 1989 Jan; 67(1):6-15. PubMed ID: 2921843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
    Chan KK; Chlebowski RT; Tong M; Chen HS; Gross JF; Bateman JR
    Cancer Res; 1980 Apr; 40(4):1263-8. PubMed ID: 6244090
    [No Abstract]   [Full Text] [Related]  

  • 5. Caffeine clearance by enzyme multiplied immunoassay technique: a simple, inexpensive, and useful indicator of liver function.
    McDonagh JE; Nathan VV; Bonavia IC; Moyle GR; Tanner AR
    Gut; 1991 Jun; 32(6):681-4. PubMed ID: 2060878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
    Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
    Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers.
    Wahlländer A; Paumgartner G
    Eur J Clin Pharmacol; 1989; 37(3):279-83. PubMed ID: 2612543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum globulin subfraction variations in liver cirrhosis and hepatoma.
    Kageyama T; Kimoto S; Toda H; Oyabu H; Watanabe I
    Bull Osaka Med Sch; 1975 Oct; 21(2):132-9. PubMed ID: 181107
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood coagulation and fibrinolysis in Ugandan patients with cirrhosis and hepatocellular carcinoma.
    Alpidovsky VK; Vogel CL; Sadikali F; Primack A
    East Afr Med J; 1974 May; 51(5):396-408. PubMed ID: 4367587
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rheumatoid factor in liver cirrhosis and hepatoma (author's transl)].
    Caballero Vallés PJ; Miramón García MA; Roldán Rincón AC; Ruiz Pérez de Villar MJ
    Med Clin (Barc); 1982 Feb; 78(3):84-7. PubMed ID: 6281590
    [No Abstract]   [Full Text] [Related]  

  • 11. [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].
    Takezaki E; Murakami S; Kagawa K; Omori H; Nishibayashi H
    Gan No Rinsho; 1990 Jan; 36(1):19-22. PubMed ID: 2153846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine clearance study in hepatocellular carcinoma.
    Tangkijvanich P; Wittayalertpanya S; Kusonsolboon T; Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 1999 Mar; 82(3):297-303. PubMed ID: 10410486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide hormones in liver cirrhosis and hepatocellular carcinoma.
    Scheuer A; Grün R; Lehmann FG
    Oncodev Biol Med; 1981; 2(1-2):1-10. PubMed ID: 6272236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum calcitonin levels in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Sagara K; Sato T
    Horm Metab Res; 1986 Jun; 18(6):421-2. PubMed ID: 3015758
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
    Collazos J
    Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of rifampin treatment on caffeine clearance in healthy man.
    Wietholtz H; Zysset T; Marschall HU; Generet K; Matern S
    J Hepatol; 1995 Jan; 22(1):78-81. PubMed ID: 7751591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
    Wang X; Yeung JH
    J Pharm Pharmacol; 2010 Aug; 62(8):1077-83. PubMed ID: 20663043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
    Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
    Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
    Niermeijer P; Gips CH; Marrink J; QUE GS
    Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.